Stock listing
9 Meters Biopharma, Inc.
Selected listing: NMTRQ · OTC · USD · US
9 Meters Biopharma, Inc. (OTC:NMTRQ), Health Technology. Latest release Feb 7, 2018: Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease…
- Ticker
- OTC:NMTRQ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About 9 Meters Biopharma, Inc.
The company focuses on developing innovative therapies for gastrointestinal diseases. Its commitment to advancing treatment options positions it as a notable player in the biopharmaceutical sector.
Latest news from 9 Meters Biopharma, Inc.
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET
February 7, 2018
Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018
January 31, 2018
CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion
January 30, 2018
Monster Digital and Innovate Biopharmaceuticals Extend Outside Closing Date for Merger
January 29, 2018
Research 9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc. company profile
View the public company page for 9 Meters Biopharma, Inc. on 6ix.
9 Meters Biopharma, Inc. news
Read company news and market updates connected to 9 Meters Biopharma, Inc..
9 Meters Biopharma, Inc. investor events
Find investor webinars, events, and replay context for 9 Meters Biopharma, Inc..